A retrospective study comparing real world adherence of Lurasidone and other atypical antipsychotics in patients with schizophrenia

Trial Profile

A retrospective study comparing real world adherence of Lurasidone and other atypical antipsychotics in patients with schizophrenia

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Lurasidone (Primary) ; Aripiprazole; Olanzapine; Quetiapine; Risperidone; Ziprasidone
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jun 2017 New trial record
    • 01 May 2017 Results published in the Current Medical Research and Opinion
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top